Maxim comments:
Sequenom, Inc. (SQNM – $2.59 – Buy – $6 target price)
We recommend that investors Buy shares of $SQNM. Shares are severely undervalued, but the company continues to be the leader in the rapidly growing NIPT market (along with Ariosa). The company is nearing the completion of the evaluation of strategic alternatives for its Bioscience division, which may be a positive
catalyst for shares.
Reverse every natural instinct and do the opposite of what you are inclined to do, and you will probably come very close to having a perfect golf swing.
Ben Hogan